Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vagina | 44 | 2021 | 841 | 5.730 |
Why?
|
Trichomonas vaginalis | 14 | 2020 | 70 | 4.010 |
Why?
|
Cervix Uteri | 24 | 2020 | 570 | 2.470 |
Why?
|
Totiviridae | 6 | 2020 | 26 | 1.980 |
Why?
|
Vaginosis, Bacterial | 11 | 2021 | 151 | 1.950 |
Why?
|
CA-125 Antigen | 9 | 2022 | 276 | 1.600 |
Why?
|
Inflammation | 54 | 2023 | 10759 | 1.590 |
Why?
|
Anti-Infective Agents | 11 | 2015 | 983 | 1.500 |
Why?
|
Epithelial Cells | 16 | 2019 | 3672 | 1.420 |
Why?
|
Vaginitis | 5 | 2017 | 49 | 1.390 |
Why?
|
Immunity, Innate | 10 | 2022 | 3045 | 1.270 |
Why?
|
Parasites | 4 | 2020 | 160 | 1.220 |
Why?
|
Bacteria, Anaerobic | 2 | 2019 | 70 | 1.220 |
Why?
|
Trichomonas Vaginitis | 3 | 2021 | 33 | 1.220 |
Why?
|
Lactobacillus | 5 | 2021 | 212 | 1.140 |
Why?
|
Cytokines | 40 | 2023 | 7373 | 1.120 |
Why?
|
Glycosphingolipids | 3 | 2015 | 73 | 1.060 |
Why?
|
Blood Proteins | 16 | 2019 | 1172 | 1.030 |
Why?
|
Interleukin-8 | 17 | 2023 | 696 | 1.020 |
Why?
|
Bacteria | 8 | 2021 | 2192 | 0.990 |
Why?
|
Immunity, Mucosal | 5 | 2020 | 483 | 0.850 |
Why?
|
Nonoxynol | 8 | 2015 | 12 | 0.840 |
Why?
|
Gestational Age | 32 | 2023 | 3577 | 0.820 |
Why?
|
Infant, Premature, Diseases | 11 | 2019 | 710 | 0.800 |
Why?
|
Herpes Genitalis | 2 | 2022 | 149 | 0.780 |
Why?
|
Secretory Leukocyte Peptidase Inhibitor | 5 | 2020 | 23 | 0.780 |
Why?
|
Disease Susceptibility | 4 | 2019 | 1788 | 0.770 |
Why?
|
Bacterial Infections | 3 | 2019 | 1389 | 0.740 |
Why?
|
HIV Seropositivity | 3 | 2022 | 959 | 0.740 |
Why?
|
Infant, Premature | 20 | 2022 | 2107 | 0.720 |
Why?
|
Host-Pathogen Interactions | 8 | 2019 | 1454 | 0.720 |
Why?
|
HIV Infections | 23 | 2022 | 17342 | 0.720 |
Why?
|
Cellulose | 4 | 2013 | 117 | 0.710 |
Why?
|
Nerve Growth Factors | 8 | 2019 | 564 | 0.710 |
Why?
|
Ovarian Neoplasms | 9 | 2022 | 4849 | 0.670 |
Why?
|
C-Reactive Protein | 16 | 2023 | 3820 | 0.670 |
Why?
|
Infant, Newborn | 65 | 2024 | 26183 | 0.660 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2019 | 48 | 0.650 |
Why?
|
Pregnancy Complications, Infectious | 5 | 2021 | 2149 | 0.620 |
Why?
|
Galectin 3 | 2 | 2021 | 240 | 0.610 |
Why?
|
Pregnancy | 54 | 2024 | 29869 | 0.610 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2021 | 389 | 0.610 |
Why?
|
Contraceptives, Oral, Hormonal | 2 | 2018 | 190 | 0.600 |
Why?
|
Female Urogenital Diseases | 3 | 2015 | 57 | 0.600 |
Why?
|
Interleukin-1beta | 8 | 2021 | 998 | 0.600 |
Why?
|
Intercellular Adhesion Molecule-1 | 10 | 2022 | 1128 | 0.580 |
Why?
|
Trichomonas Infections | 3 | 2018 | 41 | 0.580 |
Why?
|
HIV-1 | 12 | 2022 | 6858 | 0.570 |
Why?
|
Zimbabwe | 6 | 2020 | 135 | 0.560 |
Why?
|
Virus Diseases | 2 | 2021 | 718 | 0.560 |
Why?
|
Mycoplasma | 1 | 2017 | 147 | 0.560 |
Why?
|
Female | 152 | 2024 | 392203 | 0.550 |
Why?
|
Microbiology | 1 | 2017 | 70 | 0.550 |
Why?
|
Spermatozoa | 7 | 2002 | 629 | 0.540 |
Why?
|
Spermatocidal Agents | 2 | 2007 | 15 | 0.540 |
Why?
|
Contraceptive Devices, Female | 3 | 2022 | 40 | 0.530 |
Why?
|
Medroxyprogesterone | 1 | 2015 | 35 | 0.510 |
Why?
|
Vaginal Creams, Foams, and Jellies | 3 | 2022 | 62 | 0.510 |
Why?
|
Nuclease Protection Assays | 1 | 2015 | 14 | 0.500 |
Why?
|
Urinary Tract | 1 | 2019 | 313 | 0.500 |
Why?
|
Membrane Proteins | 7 | 2021 | 7847 | 0.500 |
Why?
|
Symbiosis | 2 | 2020 | 294 | 0.500 |
Why?
|
Sexually Transmitted Diseases | 2 | 2020 | 661 | 0.490 |
Why?
|
Interleukin-6 | 12 | 2022 | 3205 | 0.490 |
Why?
|
Fetal Blood | 1 | 2021 | 1347 | 0.480 |
Why?
|
Galectin 1 | 1 | 2015 | 128 | 0.480 |
Why?
|
Urinary Incontinence | 1 | 2019 | 489 | 0.480 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2015 | 1333 | 0.460 |
Why?
|
Placenta | 13 | 2019 | 1709 | 0.460 |
Why?
|
Erythropoietin | 5 | 2016 | 719 | 0.460 |
Why?
|
Infertility | 2 | 2018 | 654 | 0.460 |
Why?
|
Mucous Membrane | 6 | 2019 | 659 | 0.440 |
Why?
|
Mastitis | 1 | 2013 | 43 | 0.430 |
Why?
|
Chemokines | 11 | 2015 | 954 | 0.430 |
Why?
|
Humans | 186 | 2024 | 760740 | 0.430 |
Why?
|
Immunity | 2 | 2017 | 994 | 0.430 |
Why?
|
Inflammation Mediators | 7 | 2018 | 1884 | 0.430 |
Why?
|
Antibodies | 4 | 2013 | 2413 | 0.430 |
Why?
|
Microbial Interactions | 1 | 2013 | 74 | 0.420 |
Why?
|
Anti-Infective Agents, Local | 4 | 2008 | 247 | 0.420 |
Why?
|
Antiparasitic Agents | 1 | 2012 | 42 | 0.410 |
Why?
|
HIV Fusion Inhibitors | 1 | 2013 | 82 | 0.410 |
Why?
|
Interleukins | 5 | 2022 | 783 | 0.410 |
Why?
|
Premature Birth | 6 | 2023 | 1782 | 0.410 |
Why?
|
Pre-Eclampsia | 7 | 2023 | 1230 | 0.400 |
Why?
|
Mucin-1 | 4 | 2024 | 538 | 0.390 |
Why?
|
Semen | 7 | 2022 | 347 | 0.380 |
Why?
|
Health | 2 | 2012 | 398 | 0.380 |
Why?
|
Uganda | 5 | 2020 | 1332 | 0.380 |
Why?
|
Immunomodulation | 1 | 2015 | 548 | 0.380 |
Why?
|
Cerebral Palsy | 6 | 2021 | 474 | 0.380 |
Why?
|
Puerperal Disorders | 1 | 2013 | 300 | 0.350 |
Why?
|
Levonorgestrel | 2 | 2022 | 74 | 0.350 |
Why?
|
Infertility, Male | 5 | 1996 | 396 | 0.350 |
Why?
|
Mucins | 1 | 2013 | 568 | 0.350 |
Why?
|
Vascular Endothelial Growth Factor A | 9 | 2022 | 3492 | 0.340 |
Why?
|
Fertilization in Vitro | 1 | 2018 | 1292 | 0.340 |
Why?
|
Microcephaly | 6 | 2017 | 425 | 0.340 |
Why?
|
Sexually Transmitted Diseases, Bacterial | 1 | 2009 | 30 | 0.330 |
Why?
|
Neisseria gonorrhoeae | 2 | 2002 | 239 | 0.320 |
Why?
|
Metronidazole | 4 | 2021 | 232 | 0.320 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2022 | 2518 | 0.320 |
Why?
|
Herpesvirus 2, Human | 2 | 2022 | 191 | 0.310 |
Why?
|
Systemic Inflammatory Response Syndrome | 4 | 2016 | 619 | 0.310 |
Why?
|
Immunologic Factors | 3 | 2022 | 1589 | 0.310 |
Why?
|
Rabbits | 5 | 2019 | 4770 | 0.300 |
Why?
|
Cell Line | 12 | 2019 | 15577 | 0.300 |
Why?
|
Angiogenic Proteins | 2 | 2019 | 101 | 0.300 |
Why?
|
Models, Biological | 8 | 2018 | 9461 | 0.300 |
Why?
|
NF-kappa B | 7 | 2019 | 2481 | 0.290 |
Why?
|
Body Fluids | 2 | 2013 | 320 | 0.290 |
Why?
|
Plant Lectins | 2 | 2022 | 103 | 0.290 |
Why?
|
Adult | 60 | 2024 | 220995 | 0.290 |
Why?
|
Toll-Like Receptors | 2 | 2009 | 575 | 0.290 |
Why?
|
Vaginal Douching | 4 | 2017 | 17 | 0.290 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2023 | 1932 | 0.290 |
Why?
|
Toxicity Tests | 1 | 2007 | 115 | 0.280 |
Why?
|
Chorioamnionitis | 4 | 2012 | 156 | 0.280 |
Why?
|
Chemokine CCL5 | 6 | 2018 | 214 | 0.280 |
Why?
|
Brain-Derived Neurotrophic Factor | 3 | 2021 | 602 | 0.280 |
Why?
|
Stress, Psychological | 3 | 2023 | 4488 | 0.280 |
Why?
|
Androgen Antagonists | 3 | 2023 | 1409 | 0.280 |
Why?
|
Contraceptive Agents, Female | 3 | 2019 | 118 | 0.270 |
Why?
|
Contraceptive Agents | 2 | 2022 | 144 | 0.270 |
Why?
|
Peroxidase | 5 | 2014 | 610 | 0.270 |
Why?
|
Gene Expression | 1 | 2019 | 7569 | 0.260 |
Why?
|
Cell Adhesion Molecules | 7 | 2014 | 1602 | 0.260 |
Why?
|
Obstetric Labor, Premature | 3 | 2013 | 272 | 0.260 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 2 | 2019 | 127 | 0.260 |
Why?
|
Complement Membrane Attack Complex | 3 | 2014 | 105 | 0.260 |
Why?
|
Young Adult | 25 | 2024 | 59191 | 0.250 |
Why?
|
Autoantibodies | 5 | 2017 | 2115 | 0.250 |
Why?
|
Biomedical Research | 2 | 2019 | 3426 | 0.250 |
Why?
|
Retinopathy of Prematurity | 3 | 2019 | 439 | 0.240 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2007 | 661 | 0.240 |
Why?
|
Tumor Necrosis Factor-alpha | 9 | 2021 | 4340 | 0.240 |
Why?
|
Cell Line, Transformed | 5 | 2008 | 866 | 0.240 |
Why?
|
Immunoassay | 1 | 2008 | 744 | 0.230 |
Why?
|
beta-Defensins | 2 | 2022 | 59 | 0.230 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2006 | 352 | 0.230 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 3 | 2022 | 299 | 0.230 |
Why?
|
Fetal Development | 2 | 2021 | 769 | 0.230 |
Why?
|
CpG Islands | 2 | 2019 | 1192 | 0.220 |
Why?
|
Child Development | 8 | 2018 | 2300 | 0.220 |
Why?
|
Diet | 1 | 2021 | 8049 | 0.220 |
Why?
|
Medroxyprogesterone Acetate | 3 | 2019 | 155 | 0.220 |
Why?
|
Matrix Metalloproteinases | 5 | 2014 | 391 | 0.220 |
Why?
|
Anxiety | 1 | 2018 | 4573 | 0.210 |
Why?
|
Elafin | 1 | 2022 | 31 | 0.210 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 10 | 2015 | 3798 | 0.210 |
Why?
|
Infertility, Female | 4 | 1996 | 760 | 0.210 |
Why?
|
Anovulation | 1 | 2022 | 54 | 0.210 |
Why?
|
Epididymis | 2 | 1995 | 227 | 0.200 |
Why?
|
Carrageenan | 1 | 2022 | 71 | 0.200 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2019 | 1650 | 0.200 |
Why?
|
Leukoencephalopathies | 2 | 2017 | 256 | 0.200 |
Why?
|
Complement Activation | 2 | 2014 | 445 | 0.200 |
Why?
|
Chemokine CCL2 | 4 | 2018 | 602 | 0.190 |
Why?
|
Papillomaviridae | 5 | 2022 | 1117 | 0.190 |
Why?
|
Polymers | 1 | 2009 | 1614 | 0.190 |
Why?
|
Early Detection of Cancer | 5 | 2019 | 3196 | 0.190 |
Why?
|
Prevotella | 1 | 2021 | 80 | 0.190 |
Why?
|
Birth Weight | 4 | 2024 | 2101 | 0.190 |
Why?
|
Postmenopause | 2 | 2021 | 2511 | 0.190 |
Why?
|
Toll-Like Receptor 4 | 3 | 2015 | 578 | 0.180 |
Why?
|
Micronutrients | 1 | 2024 | 381 | 0.180 |
Why?
|
Infant, Small for Gestational Age | 2 | 2014 | 462 | 0.180 |
Why?
|
Thyrotropin | 2 | 2014 | 834 | 0.180 |
Why?
|
Oxidative Stress | 2 | 2024 | 3115 | 0.180 |
Why?
|
Oxylipins | 1 | 2021 | 53 | 0.180 |
Why?
|
Sodium Dodecyl Sulfate | 3 | 2007 | 125 | 0.180 |
Why?
|
Virion | 2 | 2013 | 422 | 0.180 |
Why?
|
Membrane Glycoproteins | 3 | 2014 | 3688 | 0.180 |
Why?
|
Depression | 3 | 2023 | 8132 | 0.180 |
Why?
|
Antigens | 3 | 1996 | 1441 | 0.180 |
Why?
|
Fetal Diseases | 2 | 2018 | 913 | 0.180 |
Why?
|
Prospective Studies | 19 | 2021 | 54364 | 0.180 |
Why?
|
Male | 57 | 2024 | 360402 | 0.170 |
Why?
|
Ascites | 1 | 2022 | 338 | 0.170 |
Why?
|
Papillomavirus Infections | 2 | 2022 | 1612 | 0.170 |
Why?
|
Fetal Membranes, Premature Rupture | 2 | 2011 | 137 | 0.170 |
Why?
|
Mexican Americans | 1 | 2021 | 163 | 0.170 |
Why?
|
Pregnancy Trimester, Third | 1 | 2022 | 582 | 0.170 |
Why?
|
Leukocytes | 2 | 2007 | 2024 | 0.170 |
Why?
|
Cognition Disorders | 4 | 2019 | 3979 | 0.170 |
Why?
|
Eczema | 1 | 2022 | 246 | 0.170 |
Why?
|
Logistic Models | 8 | 2021 | 13248 | 0.170 |
Why?
|
Nevada | 1 | 2019 | 22 | 0.170 |
Why?
|
Adolescent | 21 | 2023 | 88247 | 0.170 |
Why?
|
Infant, Low Birth Weight | 1 | 2024 | 869 | 0.170 |
Why?
|
Nutrition Surveys | 2 | 2024 | 1725 | 0.170 |
Why?
|
Carrier Proteins | 1 | 2013 | 4937 | 0.170 |
Why?
|
Hypersensitivity, Immediate | 1 | 2022 | 347 | 0.170 |
Why?
|
Bangladesh | 1 | 2021 | 732 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2022 | 218 | 0.160 |
Why?
|
Bacterial Proteins | 1 | 2013 | 3842 | 0.160 |
Why?
|
Breast Feeding | 2 | 2021 | 1355 | 0.160 |
Why?
|
Receptors, Cell Surface | 2 | 2014 | 2802 | 0.160 |
Why?
|
E-Selectin | 2 | 2014 | 577 | 0.160 |
Why?
|
Bipolar Disorder | 3 | 2022 | 5091 | 0.160 |
Why?
|
Case-Control Studies | 13 | 2019 | 22153 | 0.160 |
Why?
|
Up-Regulation | 4 | 2019 | 4117 | 0.160 |
Why?
|
Prostatic Neoplasms | 5 | 2023 | 11107 | 0.160 |
Why?
|
Vulnerable Populations | 1 | 2024 | 705 | 0.160 |
Why?
|
Neutrophils | 2 | 2023 | 3763 | 0.160 |
Why?
|
Brain Injuries | 3 | 2018 | 2053 | 0.160 |
Why?
|
Placental Insufficiency | 1 | 2019 | 50 | 0.160 |
Why?
|
Anti-HIV Agents | 4 | 2015 | 4524 | 0.160 |
Why?
|
Animals | 21 | 2023 | 168202 | 0.150 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2022 | 384 | 0.150 |
Why?
|
Environmental Pollution | 1 | 2019 | 124 | 0.150 |
Why?
|
Odds Ratio | 12 | 2019 | 9644 | 0.150 |
Why?
|
Biocompatible Materials | 1 | 2006 | 1683 | 0.150 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2022 | 846 | 0.150 |
Why?
|
Societies, Scientific | 1 | 2019 | 222 | 0.150 |
Why?
|
Fertility | 3 | 2019 | 769 | 0.150 |
Why?
|
Isoantibodies | 3 | 2002 | 669 | 0.150 |
Why?
|
Maternal Age | 1 | 2021 | 809 | 0.150 |
Why?
|
Risk Factors | 18 | 2022 | 74128 | 0.150 |
Why?
|
Trichomonas | 1 | 2017 | 3 | 0.150 |
Why?
|
Diet Surveys | 1 | 2021 | 1161 | 0.140 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2022 | 2020 | 0.140 |
Why?
|
Immunoglobulin Isotypes | 2 | 1998 | 158 | 0.140 |
Why?
|
Tennessee | 1 | 2017 | 119 | 0.140 |
Why?
|
Social Class | 3 | 2021 | 1993 | 0.140 |
Why?
|
Fish Oils | 1 | 2021 | 483 | 0.140 |
Why?
|
Pregnancy Complications | 3 | 2024 | 2948 | 0.140 |
Why?
|
Keratitis | 1 | 2020 | 241 | 0.140 |
Why?
|
Pregnancy Proteins | 3 | 2014 | 222 | 0.140 |
Why?
|
Acute-Phase Proteins | 3 | 2014 | 250 | 0.140 |
Why?
|
Contraceptives, Oral | 1 | 2019 | 553 | 0.140 |
Why?
|
Antibodies, Antiphospholipid | 1 | 1996 | 71 | 0.140 |
Why?
|
Oligospermia | 1 | 1996 | 59 | 0.140 |
Why?
|
Mathematics | 1 | 2018 | 707 | 0.140 |
Why?
|
Colony Count, Microbial | 2 | 2015 | 328 | 0.130 |
Why?
|
Lipopolysaccharides | 2 | 2021 | 2202 | 0.130 |
Why?
|
Toll-Like Receptor 8 | 1 | 2017 | 90 | 0.130 |
Why?
|
Solubility | 2 | 2015 | 1089 | 0.130 |
Why?
|
Benzalkonium Compounds | 2 | 2007 | 21 | 0.130 |
Why?
|
Developmental Disabilities | 3 | 2015 | 1509 | 0.130 |
Why?
|
Cohort Studies | 20 | 2024 | 41464 | 0.130 |
Why?
|
Pregnancy Outcome | 5 | 2019 | 2921 | 0.130 |
Why?
|
Rheumatoid Factor | 1 | 1996 | 184 | 0.130 |
Why?
|
Enterocolitis, Necrotizing | 3 | 2016 | 326 | 0.130 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2018 | 278 | 0.130 |
Why?
|
Pseudomonas Infections | 2 | 2011 | 621 | 0.130 |
Why?
|
Eye | 1 | 2020 | 713 | 0.130 |
Why?
|
Antioxidants | 1 | 2024 | 1669 | 0.130 |
Why?
|
Milk, Human | 1 | 2020 | 486 | 0.130 |
Why?
|
Chemokine CCL20 | 3 | 2016 | 64 | 0.130 |
Why?
|
Toll-Like Receptor 7 | 1 | 2017 | 165 | 0.130 |
Why?
|
Vaccines, Conjugate | 1 | 2017 | 328 | 0.120 |
Why?
|
Virus Shedding | 1 | 2016 | 109 | 0.120 |
Why?
|
Chelation Therapy | 1 | 2015 | 77 | 0.120 |
Why?
|
Parity | 2 | 2021 | 924 | 0.120 |
Why?
|
Antibodies, Antinuclear | 1 | 1996 | 342 | 0.120 |
Why?
|
Middle Aged | 29 | 2024 | 220603 | 0.120 |
Why?
|
Luminescent Measurements | 2 | 2014 | 340 | 0.120 |
Why?
|
Siderophores | 1 | 2015 | 60 | 0.120 |
Why?
|
Tobacco Smoke Pollution | 1 | 2021 | 820 | 0.120 |
Why?
|
Vitamins | 3 | 2022 | 1635 | 0.120 |
Why?
|
Deferoxamine | 1 | 2015 | 154 | 0.120 |
Why?
|
Inositol | 1 | 2015 | 215 | 0.120 |
Why?
|
Premenopause | 1 | 2019 | 1038 | 0.120 |
Why?
|
Selection, Genetic | 1 | 2019 | 868 | 0.120 |
Why?
|
Executive Function | 3 | 2018 | 1391 | 0.120 |
Why?
|
Microfilament Proteins | 1 | 2020 | 1130 | 0.120 |
Why?
|
Euthyroid Sick Syndromes | 1 | 2014 | 14 | 0.120 |
Why?
|
Receptors, Interleukin-6 | 1 | 2016 | 224 | 0.120 |
Why?
|
Electricity | 1 | 2015 | 175 | 0.120 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2015 | 193 | 0.120 |
Why?
|
Interleukin-1 | 3 | 2004 | 1248 | 0.120 |
Why?
|
Ceramides | 1 | 2015 | 200 | 0.120 |
Why?
|
Administration, Intravaginal | 2 | 2022 | 149 | 0.120 |
Why?
|
Troponin | 1 | 2018 | 502 | 0.120 |
Why?
|
DNA Methylation | 2 | 2019 | 4392 | 0.120 |
Why?
|
Interleukin-4 | 1 | 2018 | 1146 | 0.110 |
Why?
|
Antigens, CD | 3 | 2014 | 3998 | 0.110 |
Why?
|
Reading | 1 | 2018 | 531 | 0.110 |
Why?
|
Eye Proteins | 1 | 2017 | 632 | 0.110 |
Why?
|
Lactic Acid | 1 | 2019 | 1139 | 0.110 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 3 | 2012 | 664 | 0.110 |
Why?
|
Affect | 1 | 2021 | 1486 | 0.110 |
Why?
|
Fetal Growth Retardation | 2 | 2019 | 580 | 0.110 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2015 | 748 | 0.110 |
Why?
|
Body Mass Index | 5 | 2023 | 12942 | 0.110 |
Why?
|
Amniotic Fluid | 2 | 2018 | 378 | 0.110 |
Why?
|
Asthma | 2 | 2022 | 6234 | 0.110 |
Why?
|
Diabetes, Gestational | 1 | 2023 | 1250 | 0.110 |
Why?
|
Gastroesophageal Reflux | 1 | 2021 | 821 | 0.110 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2015 | 219 | 0.110 |
Why?
|
Pneumococcal Vaccines | 1 | 2017 | 397 | 0.110 |
Why?
|
Neonatal Screening | 2 | 2018 | 597 | 0.110 |
Why?
|
Nutritional Status | 1 | 2021 | 1597 | 0.110 |
Why?
|
Sexual Partners | 1 | 2018 | 800 | 0.110 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2015 | 407 | 0.110 |
Why?
|
Immune Sera | 2 | 1996 | 605 | 0.110 |
Why?
|
Electrochemical Techniques | 1 | 2013 | 93 | 0.110 |
Why?
|
Immunohistochemistry | 5 | 2015 | 11069 | 0.110 |
Why?
|
Fatty Acids | 1 | 2021 | 1808 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2191 | 0.100 |
Why?
|
Surface-Active Agents | 2 | 2004 | 150 | 0.100 |
Why?
|
Freezing | 1 | 2013 | 311 | 0.100 |
Why?
|
Evaluation Studies as Topic | 1 | 2015 | 1624 | 0.100 |
Why?
|
Dietary Supplements | 2 | 2024 | 3412 | 0.100 |
Why?
|
Interleukin-10 | 1 | 2018 | 1171 | 0.100 |
Why?
|
Drosophila Proteins | 1 | 2002 | 1698 | 0.100 |
Why?
|
Vision Disorders | 2 | 2017 | 1088 | 0.100 |
Why?
|
Gonadal Steroid Hormones | 1 | 2016 | 702 | 0.100 |
Why?
|
Strabismus | 1 | 2017 | 317 | 0.100 |
Why?
|
Cognition | 5 | 2023 | 6988 | 0.100 |
Why?
|
Memory, Short-Term | 1 | 2019 | 982 | 0.100 |
Why?
|
Bacterial Load | 1 | 2013 | 151 | 0.100 |
Why?
|
Maternal Exposure | 1 | 2019 | 1067 | 0.100 |
Why?
|
Rett Syndrome | 1 | 2014 | 163 | 0.100 |
Why?
|
Toll-Like Receptor 3 | 1 | 2012 | 97 | 0.100 |
Why?
|
Vitamin D | 4 | 2022 | 3301 | 0.100 |
Why?
|
Kidney Tubules, Proximal | 1 | 2014 | 382 | 0.100 |
Why?
|
Immune Evasion | 1 | 2015 | 363 | 0.100 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2014 | 295 | 0.100 |
Why?
|
Time Factors | 13 | 2017 | 39908 | 0.100 |
Why?
|
Angiopoietin-1 | 3 | 2018 | 122 | 0.100 |
Why?
|
Acetylglucosamine | 1 | 2013 | 189 | 0.100 |
Why?
|
Acrosome | 1 | 1991 | 10 | 0.100 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2012 | 141 | 0.100 |
Why?
|
Signal Transduction | 5 | 2015 | 23415 | 0.100 |
Why?
|
Bronchopulmonary Dysplasia | 2 | 2016 | 326 | 0.100 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2012 | 631 | 0.090 |
Why?
|
Rodentia | 1 | 1993 | 261 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 4 | 2018 | 558 | 0.090 |
Why?
|
Thyroid Diseases | 1 | 2014 | 386 | 0.090 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2011 | 97 | 0.090 |
Why?
|
Fibroblast Growth Factors | 1 | 2017 | 865 | 0.090 |
Why?
|
RNA, Double-Stranded | 1 | 2012 | 294 | 0.090 |
Why?
|
Emotions | 1 | 2023 | 2741 | 0.090 |
Why?
|
Eye Infections | 1 | 2011 | 62 | 0.090 |
Why?
|
DNA, Bacterial | 1 | 2016 | 1471 | 0.090 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1608 | 0.090 |
Why?
|
Evolution, Molecular | 1 | 2019 | 1880 | 0.090 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2018 | 691 | 0.090 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2011 | 317 | 0.090 |
Why?
|
Receptors, Virus | 1 | 2014 | 639 | 0.090 |
Why?
|
Brain Damage, Chronic | 1 | 2011 | 266 | 0.090 |
Why?
|
Bacteremia | 3 | 2013 | 977 | 0.090 |
Why?
|
Proteins | 2 | 2023 | 6030 | 0.090 |
Why?
|
Ribonuclease III | 1 | 2012 | 279 | 0.090 |
Why?
|
Intestinal Perforation | 1 | 2012 | 249 | 0.090 |
Why?
|
Overweight | 2 | 2020 | 2417 | 0.090 |
Why?
|
New England | 1 | 2013 | 1050 | 0.090 |
Why?
|
Anti-Bacterial Agents | 3 | 2021 | 7403 | 0.090 |
Why?
|
Nanostructures | 1 | 2015 | 551 | 0.090 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 3708 | 0.090 |
Why?
|
Blood Gas Analysis | 1 | 2011 | 379 | 0.090 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 1265 | 0.090 |
Why?
|
Genome, Viral | 2 | 2011 | 665 | 0.090 |
Why?
|
Mothers | 1 | 2021 | 2194 | 0.090 |
Why?
|
Menstrual Cycle | 2 | 2022 | 539 | 0.090 |
Why?
|
Umbilical Cord | 1 | 2011 | 177 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2019 | 2057 | 0.090 |
Why?
|
Mycoses | 1 | 2013 | 386 | 0.090 |
Why?
|
Child | 16 | 2023 | 80089 | 0.080 |
Why?
|
Safety | 2 | 2004 | 1149 | 0.080 |
Why?
|
Endometritis | 1 | 2009 | 49 | 0.080 |
Why?
|
Mumps | 1 | 2010 | 71 | 0.080 |
Why?
|
Oligopeptides | 1 | 2015 | 1185 | 0.080 |
Why?
|
Adenine | 1 | 2015 | 985 | 0.080 |
Why?
|
Citrus aurantiifolia | 1 | 2008 | 1 | 0.080 |
Why?
|
Environmental Pollutants | 1 | 2019 | 1277 | 0.080 |
Why?
|
Cholecalciferol | 1 | 2014 | 553 | 0.080 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2018 | 1723 | 0.080 |
Why?
|
Comorbidity | 3 | 2016 | 10507 | 0.080 |
Why?
|
Biosensing Techniques | 1 | 2015 | 647 | 0.080 |
Why?
|
Hydrocephalus | 1 | 2015 | 764 | 0.080 |
Why?
|
Reproducibility of Results | 6 | 2015 | 20077 | 0.080 |
Why?
|
Child, Preschool | 14 | 2019 | 42193 | 0.080 |
Why?
|
Polysaccharides | 1 | 2015 | 1013 | 0.080 |
Why?
|
Brain Diseases | 2 | 2015 | 1546 | 0.080 |
Why?
|
Drug Combinations | 1 | 2015 | 2048 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2015 | 6520 | 0.080 |
Why?
|
Lipopeptides | 1 | 2009 | 70 | 0.080 |
Why?
|
Poly I-C | 1 | 2009 | 112 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3776 | 0.080 |
Why?
|
United States | 10 | 2023 | 72292 | 0.080 |
Why?
|
Aged | 16 | 2024 | 169092 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2506 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9417 | 0.080 |
Why?
|
Cryopreservation | 1 | 2013 | 728 | 0.080 |
Why?
|
Environmental Exposure | 2 | 2024 | 4483 | 0.080 |
Why?
|
Child Behavior | 1 | 2014 | 848 | 0.080 |
Why?
|
Cells, Cultured | 4 | 2017 | 18937 | 0.070 |
Why?
|
Caveolin 1 | 1 | 2009 | 255 | 0.070 |
Why?
|
Obesity | 3 | 2024 | 12934 | 0.070 |
Why?
|
Kinetics | 1 | 2015 | 6370 | 0.070 |
Why?
|
Age Factors | 3 | 2021 | 18381 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3567 | 0.070 |
Why?
|
Erythrocytes | 1 | 1996 | 2410 | 0.070 |
Why?
|
Risk | 5 | 2018 | 9603 | 0.070 |
Why?
|
Hydrolysis | 1 | 2008 | 661 | 0.070 |
Why?
|
Antibodies, Bacterial | 1 | 2013 | 1464 | 0.070 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2011 | 1434 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2016 | 2160 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 472 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 1991 | 2467 | 0.070 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2006 | 121 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 476 | 0.070 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2008 | 506 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3419 | 0.070 |
Why?
|
Cell Membrane | 2 | 1998 | 3680 | 0.070 |
Why?
|
Pseudomonas aeruginosa | 2 | 2011 | 1272 | 0.070 |
Why?
|
Double-Blind Method | 5 | 2024 | 12333 | 0.070 |
Why?
|
Demography | 1 | 2011 | 1643 | 0.070 |
Why?
|
Vitamin D Deficiency | 1 | 2016 | 1388 | 0.070 |
Why?
|
Protein Binding | 2 | 2015 | 9345 | 0.070 |
Why?
|
Fluorescent Antibody Technique, Indirect | 2 | 1998 | 427 | 0.070 |
Why?
|
Chemokines, CC | 1 | 2006 | 283 | 0.060 |
Why?
|
Receptors, Interleukin-1 | 1 | 2006 | 262 | 0.060 |
Why?
|
Educational Status | 2 | 2023 | 2509 | 0.060 |
Why?
|
Epilepsy | 1 | 2021 | 3303 | 0.060 |
Why?
|
Protein Biosynthesis | 1 | 2013 | 2100 | 0.060 |
Why?
|
Tissue Adhesions | 1 | 2006 | 218 | 0.060 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 2003 | 0.060 |
Why?
|
Neuropsychological Tests | 4 | 2022 | 7050 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2018 | 5109 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2013 | 1520 | 0.060 |
Why?
|
Cerebrovascular Circulation | 1 | 2015 | 2726 | 0.060 |
Why?
|
RNA, Messenger | 3 | 2013 | 12759 | 0.060 |
Why?
|
Reproduction | 1 | 2009 | 646 | 0.060 |
Why?
|
Staphylococcus aureus | 1 | 2013 | 1457 | 0.060 |
Why?
|
Intelligence Tests | 2 | 2018 | 503 | 0.060 |
Why?
|
Prevalence | 2 | 2019 | 15702 | 0.060 |
Why?
|
Antigens, Surface | 2 | 2002 | 1606 | 0.060 |
Why?
|
Cervix Mucus | 1 | 2004 | 18 | 0.060 |
Why?
|
Reference Standards | 1 | 2008 | 1003 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 1996 | 2238 | 0.060 |
Why?
|
Angiopoietin-2 | 2 | 2018 | 172 | 0.060 |
Why?
|
Therapeutic Irrigation | 2 | 2004 | 289 | 0.060 |
Why?
|
ROC Curve | 3 | 2017 | 3575 | 0.060 |
Why?
|
Colitis | 1 | 2012 | 1234 | 0.060 |
Why?
|
Ovulation | 1 | 2004 | 181 | 0.060 |
Why?
|
Brain | 3 | 2019 | 27100 | 0.050 |
Why?
|
Chemotaxis | 1 | 2006 | 598 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11735 | 0.050 |
Why?
|
Malaria | 1 | 2013 | 1226 | 0.050 |
Why?
|
Mental Disorders | 1 | 2023 | 6826 | 0.050 |
Why?
|
Area Under Curve | 2 | 2017 | 1635 | 0.050 |
Why?
|
Interleukin-16 | 1 | 2022 | 34 | 0.050 |
Why?
|
Sperm Motility | 1 | 2004 | 266 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10754 | 0.050 |
Why?
|
Diphosphates | 1 | 2022 | 84 | 0.050 |
Why?
|
Embryo Implantation | 1 | 2004 | 270 | 0.050 |
Why?
|
Censuses | 1 | 2023 | 198 | 0.050 |
Why?
|
HIV Core Protein p24 | 1 | 2022 | 245 | 0.050 |
Why?
|
Muramidase | 1 | 2022 | 167 | 0.050 |
Why?
|
RNA, Viral | 1 | 2011 | 2838 | 0.050 |
Why?
|
Lymphocyte Antigen 96 | 1 | 2002 | 21 | 0.050 |
Why?
|
Macrophage Colony-Stimulating Factor | 2 | 2002 | 186 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2008 | 3591 | 0.050 |
Why?
|
Interleukin-1alpha | 1 | 2022 | 86 | 0.050 |
Why?
|
Betaine | 1 | 2002 | 90 | 0.050 |
Why?
|
Toll-Like Receptor 1 | 1 | 2002 | 48 | 0.050 |
Why?
|
Prognosis | 6 | 2020 | 29601 | 0.050 |
Why?
|
Lactoferrin | 1 | 2022 | 100 | 0.050 |
Why?
|
Oncogene Proteins, Viral | 1 | 2003 | 340 | 0.050 |
Why?
|
Treatment Failure | 2 | 2021 | 2635 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2023 | 14388 | 0.050 |
Why?
|
Sepsis | 2 | 2013 | 2585 | 0.050 |
Why?
|
Cluster Analysis | 3 | 2015 | 2703 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2012 | 2630 | 0.050 |
Why?
|
Follicular Phase | 1 | 2021 | 143 | 0.050 |
Why?
|
Choriocarcinoma | 2 | 2012 | 121 | 0.050 |
Why?
|
Infant | 6 | 2022 | 36157 | 0.050 |
Why?
|
Cerebral Hemorrhage | 1 | 2012 | 2642 | 0.050 |
Why?
|
Oxidoreductases | 1 | 2023 | 412 | 0.050 |
Why?
|
Cattle | 1 | 2006 | 3841 | 0.050 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2021 | 93 | 0.040 |
Why?
|
Infusions, Parenteral | 1 | 2021 | 397 | 0.040 |
Why?
|
Uterus | 1 | 2004 | 649 | 0.040 |
Why?
|
Emulsions | 1 | 2021 | 152 | 0.040 |
Why?
|
Perimenopause | 1 | 2021 | 142 | 0.040 |
Why?
|
Neoplasms | 2 | 2019 | 22131 | 0.040 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39062 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2014 | 546 | 0.040 |
Why?
|
Cyclothymic Disorder | 1 | 2020 | 42 | 0.040 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2009 | 2197 | 0.040 |
Why?
|
Longitudinal Studies | 4 | 2021 | 14599 | 0.040 |
Why?
|
Cell Transformation, Viral | 1 | 2001 | 526 | 0.040 |
Why?
|
Osmolar Concentration | 2 | 2015 | 659 | 0.040 |
Why?
|
Cephalometry | 1 | 2021 | 382 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2022 | 629 | 0.040 |
Why?
|
Phylogeny | 3 | 2011 | 2805 | 0.040 |
Why?
|
Europe | 2 | 2017 | 3415 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2020 | 26065 | 0.040 |
Why?
|
Keratinocytes | 1 | 2003 | 790 | 0.040 |
Why?
|
HIV | 1 | 2007 | 1580 | 0.040 |
Why?
|
South Africa | 2 | 2015 | 1843 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2022 | 850 | 0.040 |
Why?
|
Pneumonia | 1 | 2011 | 2143 | 0.040 |
Why?
|
Proteinase Inhibitory Proteins, Secretory | 1 | 1999 | 48 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2002 | 540 | 0.040 |
Why?
|
Infant, Extremely Low Birth Weight | 1 | 2019 | 83 | 0.040 |
Why?
|
Cell Survival | 2 | 2006 | 5780 | 0.040 |
Why?
|
Body Weight | 2 | 2021 | 4615 | 0.040 |
Why?
|
Guinea Pigs | 2 | 1993 | 1310 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 702 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2023 | 4910 | 0.040 |
Why?
|
Vaginal Smears | 2 | 2018 | 499 | 0.040 |
Why?
|
Cross Reactions | 2 | 1993 | 816 | 0.040 |
Why?
|
Autoimmunity | 2 | 1996 | 1350 | 0.040 |
Why?
|
Interleukin-7 | 1 | 1999 | 143 | 0.040 |
Why?
|
Progesterone | 1 | 2022 | 742 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2022 | 908 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12719 | 0.040 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2018 | 116 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2022 | 7995 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2015 | 2495 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13635 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2003 | 6126 | 0.040 |
Why?
|
Gonorrhea | 1 | 2001 | 346 | 0.040 |
Why?
|
Sperm Agglutination | 1 | 1996 | 1 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2018 | 398 | 0.040 |
Why?
|
Severity of Illness Index | 4 | 2018 | 15829 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2018 | 254 | 0.030 |
Why?
|
Cricetinae | 2 | 1993 | 2424 | 0.030 |
Why?
|
Virus Cultivation | 1 | 2016 | 88 | 0.030 |
Why?
|
Apoptosis | 1 | 2013 | 9476 | 0.030 |
Why?
|
Semen Analysis | 1 | 2019 | 236 | 0.030 |
Why?
|
Retrospective Studies | 8 | 2019 | 80583 | 0.030 |
Why?
|
Antigen-Antibody Complex | 1 | 1998 | 509 | 0.030 |
Why?
|
Nitrous Acid | 1 | 2015 | 8 | 0.030 |
Why?
|
Risk Assessment | 2 | 2014 | 23974 | 0.030 |
Why?
|
T-Lymphocytes | 4 | 2018 | 10175 | 0.030 |
Why?
|
Ultrasonography | 3 | 2018 | 5965 | 0.030 |
Why?
|
Injections | 1 | 2019 | 832 | 0.030 |
Why?
|
Keratins | 1 | 1997 | 498 | 0.030 |
Why?
|
Dinoprostone | 1 | 1999 | 597 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1754 | 0.030 |
Why?
|
Prenatal Care | 1 | 2023 | 1140 | 0.030 |
Why?
|
Placebos | 2 | 2013 | 1667 | 0.030 |
Why?
|
Recurrence | 2 | 2021 | 8426 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1409 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18220 | 0.030 |
Why?
|
Reference Values | 2 | 2004 | 4919 | 0.030 |
Why?
|
Endocrine Disruptors | 1 | 2019 | 264 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2021 | 2669 | 0.030 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58919 | 0.030 |
Why?
|
Body Height | 1 | 2021 | 1565 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2013 | 17630 | 0.030 |
Why?
|
Uromodulin | 1 | 2014 | 44 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2015 | 240 | 0.030 |
Why?
|
Antigens, Differentiation | 1 | 1997 | 908 | 0.030 |
Why?
|
Asymptomatic Infections | 1 | 2015 | 131 | 0.030 |
Why?
|
Limit of Detection | 1 | 2015 | 273 | 0.030 |
Why?
|
Complement C3a | 1 | 2014 | 66 | 0.030 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2016 | 233 | 0.030 |
Why?
|
Receptors, IgG | 1 | 1997 | 558 | 0.030 |
Why?
|
Complement C5a | 1 | 2014 | 100 | 0.030 |
Why?
|
Parturition | 1 | 2018 | 447 | 0.030 |
Why?
|
Tumor Necrosis Factors | 1 | 2014 | 107 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2252 | 0.030 |
Why?
|
Transfection | 1 | 2002 | 5765 | 0.030 |
Why?
|
Escherichia coli | 1 | 2006 | 4210 | 0.030 |
Why?
|
Chemokine CXCL10 | 1 | 2015 | 309 | 0.030 |
Why?
|
Family Characteristics | 1 | 2019 | 992 | 0.030 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2015 | 281 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15250 | 0.030 |
Why?
|
Adiposity | 1 | 2023 | 1879 | 0.030 |
Why?
|
Lipocalins | 1 | 2014 | 161 | 0.030 |
Why?
|
Agglutination Tests | 1 | 1993 | 41 | 0.030 |
Why?
|
beta 2-Microglobulin | 1 | 2014 | 328 | 0.030 |
Why?
|
Opsonin Proteins | 1 | 2013 | 144 | 0.030 |
Why?
|
Protein Precursors | 1 | 1997 | 1131 | 0.030 |
Why?
|
Immunosorbent Techniques | 1 | 1993 | 174 | 0.030 |
Why?
|
Environmental Monitoring | 1 | 2019 | 1460 | 0.030 |
Why?
|
Chemokine CCL4 | 1 | 2012 | 126 | 0.030 |
Why?
|
Africa | 1 | 2015 | 714 | 0.030 |
Why?
|
Uterine Neoplasms | 2 | 2012 | 1420 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2003 | 2985 | 0.030 |
Why?
|
Rwanda | 1 | 2015 | 656 | 0.030 |
Why?
|
Serum Amyloid A Protein | 1 | 2012 | 126 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2014 | 592 | 0.030 |
Why?
|
Mice | 5 | 2023 | 81368 | 0.030 |
Why?
|
Osteopontin | 1 | 2014 | 301 | 0.030 |
Why?
|
Biodiversity | 1 | 2015 | 345 | 0.030 |
Why?
|
Gram-Positive Bacteria | 1 | 2013 | 176 | 0.030 |
Why?
|
Plasmodium berghei | 1 | 2013 | 159 | 0.030 |
Why?
|
Blood Specimen Collection | 1 | 2013 | 238 | 0.020 |
Why?
|
Kenya | 1 | 2015 | 757 | 0.020 |
Why?
|
Bacterial Capsules | 1 | 2013 | 243 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2009 | 5863 | 0.020 |
Why?
|
Antibody Formation | 1 | 1996 | 1390 | 0.020 |
Why?
|
Orchiectomy | 1 | 2014 | 463 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2012 | 119 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2017 | 990 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36401 | 0.020 |
Why?
|
Sperm Capacitation | 1 | 1991 | 21 | 0.020 |
Why?
|
Macrophage Migration-Inhibitory Factors | 1 | 2011 | 108 | 0.020 |
Why?
|
Language Development | 1 | 2013 | 183 | 0.020 |
Why?
|
Gram-Negative Bacteria | 1 | 2013 | 271 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2014 | 699 | 0.020 |
Why?
|
Thiocyanates | 1 | 1991 | 70 | 0.020 |
Why?
|
Culture Techniques | 1 | 2011 | 531 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 1999 | 1962 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2015 | 1033 | 0.020 |
Why?
|
Mutation | 1 | 2015 | 30015 | 0.020 |
Why?
|
Fluoresceins | 1 | 1991 | 235 | 0.020 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1991 | 222 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2012 | 436 | 0.020 |
Why?
|
Sequence Homology | 1 | 2011 | 196 | 0.020 |
Why?
|
Rhodamines | 1 | 1991 | 178 | 0.020 |
Why?
|
Health Surveys | 1 | 2021 | 4036 | 0.020 |
Why?
|
Swine | 1 | 2021 | 5908 | 0.020 |
Why?
|
HLA-DR Antigens | 1 | 2012 | 601 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 7805 | 0.020 |
Why?
|
Proteinuria | 1 | 2013 | 605 | 0.020 |
Why?
|
Capsid | 1 | 2013 | 433 | 0.020 |
Why?
|
Fungi | 1 | 2013 | 338 | 0.020 |
Why?
|
Interferon-gamma | 1 | 1999 | 3145 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2017 | 2328 | 0.020 |
Why?
|
Ultrasonography, Doppler | 1 | 2012 | 462 | 0.020 |
Why?
|
Albuminuria | 1 | 2014 | 655 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2012 | 486 | 0.020 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2011 | 361 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2013 | 13442 | 0.020 |
Why?
|
Microfluidics | 1 | 2015 | 651 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3037 | 0.020 |
Why?
|
Aging | 2 | 2015 | 8700 | 0.020 |
Why?
|
Visual Fields | 1 | 2017 | 1062 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2017 | 1349 | 0.020 |
Why?
|
Receptors, Cytokine | 1 | 2010 | 257 | 0.020 |
Why?
|
Fetus | 1 | 2017 | 1862 | 0.020 |
Why?
|
Women's Health | 1 | 2019 | 2066 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2015 | 2925 | 0.020 |
Why?
|
Environment | 1 | 2015 | 1123 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2015 | 2079 | 0.020 |
Why?
|
Adrenal Glands | 1 | 2011 | 552 | 0.020 |
Why?
|
Lectins | 1 | 1991 | 489 | 0.020 |
Why?
|
Cryoelectron Microscopy | 1 | 2013 | 650 | 0.020 |
Why?
|
Patient Discharge | 1 | 2022 | 3442 | 0.020 |
Why?
|
Metagenome | 1 | 2012 | 448 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2013 | 9171 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1662 | 0.020 |
Why?
|
Monocytes | 2 | 2012 | 2565 | 0.020 |
Why?
|
Hydatidiform Mole | 1 | 2011 | 255 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2012 | 753 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2015 | 1936 | 0.020 |
Why?
|
Species Specificity | 1 | 1993 | 2410 | 0.020 |
Why?
|
Temperature | 1 | 2015 | 2224 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2010 | 433 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2851 | 0.020 |
Why?
|
Necrosis | 1 | 2012 | 1610 | 0.020 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2013 | 600 | 0.020 |
Why?
|
Contraception | 1 | 1991 | 347 | 0.020 |
Why?
|
Adiponectin | 1 | 2013 | 1107 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 21339 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2011 | 1989 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8619 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3501 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 16968 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2015 | 1882 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 1700 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1745 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2597 | 0.020 |
Why?
|
Isoenzymes | 1 | 2011 | 1687 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 64572 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14649 | 0.020 |
Why?
|
Medicaid | 1 | 2019 | 2814 | 0.020 |
Why?
|
Leptin | 1 | 2013 | 1595 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2015 | 3769 | 0.020 |
Why?
|
Autistic Disorder | 1 | 2014 | 1219 | 0.020 |
Why?
|
Head | 1 | 2011 | 922 | 0.020 |
Why?
|
Hemodynamics | 1 | 2015 | 4160 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2014 | 1859 | 0.010 |
Why?
|
Rats | 2 | 1993 | 23716 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3794 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2013 | 22117 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2013 | 2465 | 0.010 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2003 | 109 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4745 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6763 | 0.010 |
Why?
|
Viral Proteins | 1 | 2010 | 1799 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4512 | 0.010 |
Why?
|
Endometrium | 1 | 2004 | 403 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10708 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2015 | 7583 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2013 | 4533 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11118 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 1996 | 3752 | 0.010 |
Why?
|
Hormones | 1 | 2004 | 869 | 0.010 |
Why?
|
Survival Analysis | 1 | 2013 | 10072 | 0.010 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1285 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4739 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4058 | 0.010 |
Why?
|
Phenotype | 1 | 1997 | 16572 | 0.010 |
Why?
|
Isoantigens | 1 | 2002 | 551 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12420 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3606 | 0.010 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2002 | 888 | 0.010 |
Why?
|
Communication | 1 | 2013 | 3851 | 0.010 |
Why?
|
Regression Analysis | 1 | 2007 | 6339 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13495 | 0.010 |
Why?
|
HeLa Cells | 1 | 2002 | 3088 | 0.010 |
Why?
|
Electroencephalography | 1 | 2011 | 6240 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11874 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1998 | 1597 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2006 | 3451 | 0.010 |
Why?
|
Hypertension | 1 | 2013 | 8532 | 0.010 |
Why?
|
HIV Antibodies | 1 | 1998 | 1302 | 0.010 |
Why?
|
Macrophages | 1 | 2002 | 5758 | 0.000 |
Why?
|